Does blood pressure differ between users and non-users of hormone replacement therapy? The Women's Health in the Lund Area (WHILA) study

Blood Pressure

Volumn 11, Issue 4, 2002, Pages 240-243

  Enström, Inger ^a   Lidfeldt, Jonas ^a   Lindholm, Lars H ^a   Nerbrand, Christina ^a   Pennert, Kjell ^a   Samsioe, Göran ^a  

^a Kävlinge Health Centre   (Sweden)

Author keywords

Ambulatory blood pressure; Hormone replacement therapy; Office blood pressure

Indexed keywords

ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; HEART RATE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZATION; STATISTICAL SIGNIFICANCE; SWEDEN; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; COMPARATIVE STUDY; MIDDLE AGED;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; POSTMENOPAUSE;

EID: 0036381243     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/08037050213757     Document Type: Article

References (35)

1. Castelli WP. Cardiovascular disease in women. Am J Obstet Gynecol 1988; 158: 1553-60.
2. Cauley JA, Seelay DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women. Study of Osteoporosic Fractures Research Group. Ann Intern Med 1995; 122: 9-16.
3. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985; 102: 319-24.
4. Hirvonen E, Lamberg-Allardt C, Lankinen KS, Geurts P, Wilen-Rosenqvist G. Transdermal oestradiol gel in the treatment of the climacterium: a comparison with oral therapy. Br J Obstet Gynecol 1997; 104 Suppl 16: S19-25.
5. Samsioe G. Cardioprotection by hormone replacement therapy. Contemp Rev Obstet Gynecol 1995; 7: 118-24.
6. Barrett-Connor E. Hormone replacement therapy. BMJ 1998;317:457-61.
7. Hemminki E, McPherson K. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. BMJ 1997; 315: 149-53.
8. Editorial. Hormone replacement therapy again. Risk-benefit relation differs between populations and individuals. BMJ 1998;316:1842-4.
9. Dawber TR. The Framingham study. The epidemiology of atheriosclerosic disease. Cambridge, MA: Harvard University Press, 1980: 30-52.
10. Falkeborn M, Persson I, Terént A, Adami H-O, Lithell H, Bergström R. Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden. Arch Intern Med 1993; 153: 1201-9.
11. Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal oestrogen treatment and stroke: a prospective study. BMJ 1988; 297: 519-22.
12. Hazzard WR. Estrogen replacement and cardiovascular disease: serum lipids and blood pressure effects. Am J Obstet Gynecol 1989; 161: 1847-53.
13. Kaplan NM. Estrogen replacement therapy. Effect on blood pressure and other cardiovascular risk factors. J Reprod Med 1985; 30: 802-4.
14. The Writing Group for the PEP1 Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995; 273: 199-208.
15. Kornhauser C, Malacara JM, Garay ME, Pérez-Luque LE. The effect of hormone replacement therapy on blood pressure and cardiovascular risk factors in menopausal women with moderate hypertension. J Hum Hypertens 1997; 11: 405-11.
16. Tepper R, Goldberger S, May JY, Luz IJ, Beyth Y. Hormonal replacement therapy in postmenopausal women and cardiovascular disease: an overview. Obstet Gynecol Surv 1992; 47: 426-31.
17. van Ittersum FJ, van Baal WM, Kenemans P, et al. Ambulatory-not office-blood pressures decline during hormone replacement therapy in healthy postmenopausal women. Am J Hypertens 1998; 11: 1147-52.
18. Wu Z, Wu X, Zhang Y. Relationship of menopausal status and sex hormones to serum lipids and blood pressure. Inter J Epidemiol 1990; 19: 297-302.
19. Manheim K, Ahlm H, Milsom I, Svensson A. Transdermal oestrogen reduces daytime blood pressure in hypertensive women. J Hum Hypertens 1998; 12: 323-7.
20. Akkad AA, Halligan AW, Abrams K, al-Azzawi F. Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy. Obstet Gynecol 1997; 89: 97-103.
21. Harvey PJ, Wing LM, Savage J, Molloy D. The effects of different types and doses of oestrogen replacement therapy on clinic and ambulatory blood pressure and the renin-angotensin system in normotensive postmenopausal women. J Hypertens 1999; 17: 405-11.
22. Hassager C, Riis BJ, Strom V, Guyene TT, Christiansen C. The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation 1997; 76: 753-8.
23. Mercuro G, Zoncu S, Piano D, Pilia I, Lao A, Melis GB, Cherchi A. Estradiol-17beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension. Am J Hypertens 1998; 11: 909-13.
24. Pfeffer RI, Kurasoki TT, Charlton SK. Estrogen use and blood pressure in later life. Am J Epidem 1979; 110: 469-78.
25. Mashchank CA, Lobo RA. Estrogen replacement therapy and hypertension. J Reprod Med 1985; 30 Suppl: S805-10.
26. Rödström K, Bengtsson C, Lissner L, Björkelund C. Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: prospective cohort study in Gothenburg, Sweden. BMJ 1999; 319: 890-3.
27. O'Brien E, Pery I, Sheridan J, Atkins N, O'Malley K. Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society protocol. J Hypertens 1991; 9: 573-4.
28. Laragh JH, Sealey JE, Ledingham JGG, et al. Oral contraceptives: renin, aldosterone and high blood pressure. JAMA 1967; 918-22.
29. Crane MG, Harris JJ, Winsor WIII. Hypertension, oral contraceptive agents, and conjugated estrogens. Ann Intern Med 1971; 74: 13-21
30. Weinberger MH, Collins RD, Dowdy AJ et al. Hypertension induced by oral contraceptives containing estrogen and gestagen: effects on plasma renin activity and aldosterone excretion. Ann Intern Med 1969; 71: 891-902.
31. Angerer P, Stork S, von Schacky C. Influence of 17beta-oestadiol on blood presure of postmenopausal women at high vascular risk. J Hypertens 2001; 19: 2135-42.
32. Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery A. The influence of menopause on blood pressure. J Hum Hypertens 1989; 3: 427-33.
33. Lindquist O, Bengtsson C. Serum lipids, arterial blood pressure and body weight in relation to the menopause: results from a population study of women in Göteborg, Sweden. Scand J Clin Lab Invest 1980; 40: 629-36.
34. Amigoni S, Morelli P, Parazzini F, Chatenoud L. Determinants of elevated blood pressure in women around menopause: results from a cross-sectional study in Italy. Maturitas 2000; 34: 25-34.
35. Jacobs HS, Loeffler FE. Postmenopausal hormone replacement therapy. Regular review. BMJ 1992; 305: 1403-8.